2016
DOI: 10.5935/1806-0013.20160049
|View full text |Cite
|
Sign up to set email alerts
|

Post-chemotherapy neuropathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
5
0
6

Year Published

2018
2018
2022
2022

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(12 citation statements)
references
References 25 publications
1
5
0
6
Order By: Relevance
“…One important datum found was that those patients who had a greater number of interventions (chemotherapy, radiotherapy, and surgery) had a significantly larger proportion of symptoms characteristic of NP. This result shows that the combination of interventions could indeed increase the risk of development of NP 8,[16][17][18] . It is well known that the appearance of peripheral neuropathy, induced by chemotherapy, is affected by the dose, the cumulative effect, and by the class of chemotherapeutic agent used, especially when the chemical used in chemotherapy is an alkaloid, a taxane, or a platinum complex 8,10,[15][16][17] .…”
Section: Discussionmentioning
confidence: 99%
“…One important datum found was that those patients who had a greater number of interventions (chemotherapy, radiotherapy, and surgery) had a significantly larger proportion of symptoms characteristic of NP. This result shows that the combination of interventions could indeed increase the risk of development of NP 8,[16][17][18] . It is well known that the appearance of peripheral neuropathy, induced by chemotherapy, is affected by the dose, the cumulative effect, and by the class of chemotherapeutic agent used, especially when the chemical used in chemotherapy is an alkaloid, a taxane, or a platinum complex 8,10,[15][16][17] .…”
Section: Discussionmentioning
confidence: 99%
“…The antineoplastic agents used in the studies in this review (Oxaliplatin, Cisplatin, Vincristine and Bortezomib) affect the nervous system differently, and all can reach the ganglion cells of the dorsal roots to the distal axons 27 . The use of different chemotherapeutic agents across the studies included in this review may explain some of the variability in the findings 28 .…”
Section: Discussionmentioning
confidence: 99%
“…Os principais efeitos adversos são náuseas, vômito, mucosite, alopecia, mielotoxicidade, diarreia e Neuropatia Periférica Induzida por Quimioterapia (NPIQ). A NPIQ é definida como uma complicação neurológica comum e potencialmente limitante no tratamento oncológico e é caracterizada como uma polineuropatia sensitivo-motora simétrica, bilateral, geralmente distal, de caráter progressivo, podendo ser aguda ou crônica (SIMÃO et al, 2015;CAPONERO, MONTARROYOS;TAHAMTANI, 2016).…”
Section: Capitulounclassified